NuvOx Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	92	-	-
Enterprise Value	119	-	-
Debt / Equity Ratio	-0.87	-0.89	-1.15
Debt / EBITDA Ratio	-2.39	-1.33	-1.47
Debt / FCF Ratio	-15.67	-10.99	-2.84
Net Debt / Equity Ratio	-0.86	-0.89	-0.97
Net Debt / EBITDA Ratio	-2.36	-1.32	-1.24
Net Debt / FCF Ratio	-15.52	-10.92	-2.39
Quick Ratio	0.05	0.04	1.14
Interest Coverage	-907.38	-17213.00	-
Return on Equity (ROE)	34.78%	64.96%	71.90%
Return on Assets (ROA)	-	-1077.27%	-228.24%
Return on Invested Capital (ROIC)	-	-	-348.88%
Return on Capital Employed (ROCE)	214.94%	671.86%	-531.79%